Results 121 to 130 of about 6,404 (193)

Herpes zoster hospitalization burden in Spain during the initial period of recombinant zoster vaccine implementation. [PDF]

Hum Vaccin Immunother
Blanc JM, Jimeno-Sanz I, Hernández-Barrera V, Gil-de-Miguel Á.   +3 more
europepmc   +1 more source

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years. [PDF]

Open Forum Infect Dis
Leon R, Diez-Domingo J, Andrews C, Arns da Cunha C, Choo EJ, Hui DSC, Cunningham AL, Eto T, Icardi G, McNeil SA, Põder A, Kosina P, Rombo L, Schwarz TF, Tinoco JC, Yu CJ, Wang J, Soni J, Tsang M, Strezova A, Salaun B, Mwakingwe-Omari A.   +21 more
europepmc   +1 more source

The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGFβ. [PDF]

PLoS Pathog
Johnson MJ, Crotteau M, Ghosh D, Vu T, Trinity L, Marches R, Ucar D, Levin MJ, Weinberg A.   +8 more
europepmc   +1 more source

Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases. [PDF]

J Infect Dis
Constenla D, Lonnet G, Aris E, Rk R, Servotte N, Mwakingwe-Omari A, Alsdurf H, Yun H.   +7 more
europepmc   +1 more source

Real-world study: Analysis of post-marketing safety for recombinant zoster vaccine in Shandong, China. [PDF]

Hum Vaccin Immunother
Li H, Xie M, Qiu X, Kang X, Li F, Xu A, Zhang L.   +6 more
europepmc   +1 more source

Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort. [PDF]

Vaccines (Basel)
Valentini S, Sota J, Fineschi I, Conticini E, Garcia-Gonzalez E, D'Ignazio E, Bardelli M, Gentileschi S, Fabbroni M, Bellisai F, Falsetti P, Selvi E, Cantarini L, Frediani B, Baldi C.   +14 more
europepmc   +1 more source

Using double-negative controls to adjust for healthy-user bias in a recombinant zoster vaccine safety study. [PDF]

Am J Epidemiol
Li K, Emerman I, Cook AJ, Fireman BH, Sundaram M, Tseng HX, Weintraub ES, Yu O, Nelson JL, Shi X.   +9 more
europepmc   +1 more source

Mitigating Vaccine Disparities Through Faith-Based Intervention: A Pre-Post Analysis of Recombinant Zoster Vaccine Knowledge and Acceptance in Socially Vulnerable Racial and Ethnic Minoritized Communities. [PDF]

Infect Dis Ther
Abdul-Mutakabbir JC, Abdul-Mutakabbir R, Casey SJ.   +2 more
europepmc   +1 more source

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024. [PDF]

Hum Vaccin Immunother
Li Y, Xia H, Zhang H, Lu Y, Zhou H, Yu R, Huang P.   +6 more
europepmc   +1 more source